Gene · 9049
Papers3,088
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,088
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Properties and Applications of Graphene and Its Derivatives in Biosensors for Cancer Detection: A Comprehensive Review. | Biosensors (Basel) | 2022 | 35624570 | PubTator, text mining | PubMed |
| Infection and reinfection with SARS-CoV-2 in cancer patients: A cohort study. | Exp Ther Med | 2022 | 35619634 | PubTator, text mining | PubMed |
| Vertical structure of conventionally neutral atmospheric boundary layers. | Proc Natl Acad Sci U S A | 2022 | 35609201 | PubTator, text mining | PubMed |
| The Ubiquitous Human Skin Commensal Staphylococcus hominis Protects against Opportunistic Pathogens. | mBio | 2022 | 35608301 | PubTator, text mining | PubMed |
| Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands. | Endocrine | 2022 | 35604630 | PubTator, text mining | PubMed |
| Editorial for May/June Issue of AACE Clinical Case Reports. | AACE Clin Case Rep | 2022 | 35602881 | PubTator, text mining | PubMed |
| Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor-Interacting Protein-mutated Pediatric Somatotropinoma. | AACE Clin Case Rep | 2022 | 35602875 | PubTator, text mining | PubMed |
| Assessment of the effects of organic vs. inorganic arsenic and mercury in Caenorhabditis elegans. | Curr Res Toxicol | 2022 | 35602005 | PubTator, text mining | PubMed |
| Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants. | Sci Rep | 2022 | 35595798 | PubTator, text mining | PubMed |
| Stereotactic Radiotherapy Ablation and Atrial Fibrillation: Technical Issues and Clinical Expectations Derived From a Systematic Review. | Front Cardiovasc Med | 2022 | 35592393 | PubTator, text mining | PubMed |
| Quo Vadis, Nanothermite? A Review of Recent Progress. | Materials (Basel) | 2022 | 35591548 | PubTator, text mining | PubMed |
| Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing. | Front Endocrinol (Lausanne) | 2022 | 35586626 | PubTator, text mining | PubMed |
| Complex tools and motor-to-mechanical transformations. | Sci Rep | 2022 | 35577883 | PubTator, text mining | PubMed |
| A Survey of Multifingered Robotic Manipulation: Biological Results, Structural Evolvements, and Learning Methods. | Front Neurorobot | 2022 | 35574228 | PubTator, text mining | PubMed |
| Microstructure and Intrinsic Strain of Nanocrystals in Ferroelectric (Na,K)NbO3 Nanofibers. | Nanomaterials (Basel) | 2022 | 35564250 | PubTator, text mining | PubMed |
| Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. | J Cell Biol | 2022 | 35551578 | PubTator, text mining | PubMed |
| DIFFERENTIAL EXPRESSION PATTERN OF AIP, UCKL1, AND PKN1 GENES IN PROSTATE CANCER PATIENTS. | Exp Oncol | 2022 | 35548962 | PubTator, text mining | PubMed |
| Pancreatic INS-1 β-Cell Response to Thapsigargin and Rotenone: A Comparative Proteomics Analysis Uncovers Key Pathways of β-Cell Dysfunction. | Chem Res Toxicol | 2022 | 35544339 | PubTator, text mining | PubMed |
| Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial. | BMC Cardiovasc Disord | 2022 | 35538431 | PubTator, text mining | PubMed |
| Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer. | NPJ Breast Cancer | 2022 | 35538119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9049/papers?page=51